Search Results - boris+chobrutskiy

3 Results

Sort By:

Cancer Patients with an Anti-Epstein-Barr Virus (EBV) Immune Response Show Improved Outcomes

Advantages: Cancers with an adaptive immune response (T cell and antibody response) to EBV correlate with better outcomes: tested in ovarian cancer, stomach adenocarcinoma, Burkitt lymphoma, and diffused large B cell lymphoma Could be developed into a potential predictive biomarker that utilizes antibody and/or T cell receptor CDR3 sequencing...

Published: 8/29/2024 | Inventor(s): George Blanck, Rahul Jain, Taha Huda, Srijit Paul, Boris Chobrutskiy, Andrea Chobrutskiy, Nandini Goel, Madeline Baker, Joanna Song, Veda Vangala, Michael Diaz

Keywords(s): Cancer Diagnostics

Category(s): Technology Classifications > Cancer > Cancer Diagnostics, Technology Classifications > Medical > Medical Diagnostics

Tau as a Biomarker for Low Grade Glioma (LLG) and Neuroblastoma Patients

Competitive Advantages A prognostic biomarker for LGG and neuroblastoma May be used to develop new treatments May increase patient survivability Summary The association of the MAPT gene (microtubule-associated protein Tau), which encodes Tau protein, with various tauopathies and other neurological disorders has long been established. However,...

Published: 9/9/2024 | Inventor(s): George Blanck, Saif Zaman, Boris Chobrutskiy

Keywords(s):

Category(s): Technology Classifications > Cancer, Technology Classifications > Medical > Oncology

Immune Receptor Mutant Peptide Complementarity Scoring for Therapy Design and Prognosis

Competitive Advantages A prognostic genomic-based method Improved survival prediction accuracies Improved immunotherapy effectiveness predictions Measures tumor immune activity Summary USF researchers have developed a genomics-based method to provide prognoses based on tumor immune activity. Also provided are indications for components for...

Published: 9/30/2022 | Inventor(s): George Blanck, Boris Chobrutskiy

Keywords(s):

Category(s): Technology Classifications > Cancer > Cancer Diagnostics, Technology Classifications > Cancer